BERIRAB P 300IU INJECTION

BERIRAB P 300IU INJECTION is not a vaccine and cannot prevent rabies infection. It is used to provide immediate passive immunity to individuals exposed to rabies who may not yet have developed their immune response. A rabies vaccine is typically given with BERIRAB P 300IU INJECTION to provide long-term protection against rabies.

BERIRAB P 300IU INJECTION can be given to individuals with compromised immune systems who have been exposed to rabies. However, it is important to consult with a healthcare provider before receiving this medicine, as these individuals may be at a higher risk of developing adverse reactions.

BERIRAB P 300IU INJECTION may be given to individuals who have already received a rabies vaccine as a part of post-exposure prophylaxis. However, the timing of the vaccine and BERIRAB P 300IU INJECTION administration may differ depending on the individual's vaccination history and the severity of the exposure.

BERIRAB P 300IU INJECTION may interfere with the immune response to live virus vaccines, including measles, mumps, rubella, and varicella. Therefore, individuals who have received blood transfusions or products should consult with a healthcare provider before receiving this injection to determine the appropriate timing of any live virus vaccines.

BERIRAB P 300IU INJECTION may be associated with some individuals' increased risk of Guillain-Barré syndrome. Therefore, individuals with a history of Guillain-Barré syndrome should consult a healthcare provider before receiving this injection.

The protective effect of BERIRAB P 300IU INJECTION varies depending on the individual's immune response and the severity of the rabies exposure. It provides immediate passive immunity, but the duration of protection is limited. A rabies vaccine is typically given with this injection to provide long-term protection against rabies.

Yes, BERIRAB P 300IU INJECTION may interfere with the immune response to live virus vaccines like measles, mumps, rubella, and varicella. It is important to inform your healthcare provider about all medications you are taking before receiving this injection.

While receiving BERIRAB P 300IU INJECTION, you should carefully read and understand the warnings and precautions. Report any infusion reactions to your doctor. If you are pregnant or breastfeeding, consult your healthcare provider. Always inform your provider about any allergies, medical conditions, or other medications you take. Maintain a healthy and balanced diet.

BERIRAB P 300IU INJECTION contains HUMAN RABIES IMMUNOGLOBULIN.

BERIRAB P 300IU INJECTION is primarily used for immediate protection after potential exposure to the rabies virus. It is given as part of post-exposure prophylaxis, usually along with the rabies vaccine, to provide rapid antibodies. It is an antiviral medication administered by injection.